(Q33732738)

29 July 2017

1 reference

title

Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

11

1 reference

29 July 2017

Berlyn KA

1

1 reference

29 July 2017

Ponniah S

2

1 reference

29 July 2017

Stass SA

3

1 reference

29 July 2017

Malone JG

4

1 reference

29 July 2017

Hamlin-Green G

5

1 reference

29 July 2017

Lim JK

6

1 reference

29 July 2017

Cottler-Fox M

7

1 reference

29 July 2017

Tricot G

8

1 reference

29 July 2017

Alexander RB

9

1 reference

29 July 2017

Mann DL

10

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

published in

Journal of Biotechnology

1 reference

29 July 2017

volume

73

1 reference

29 July 2017

issue

2-3

1 reference

29 July 2017

page(s)

155-179

1 reference

A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Loss of HLA class I expression in prostate cancer: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

T-cell recognition of human melanoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Gene therapy for urologic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Molecular characterization of defective antigen processing in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Dendritic cells: origin and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Human gene therapy for melanoma: CT-guided interstitial injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2899%2900118-2

7 January 2021

10.1016/S0168-1656(99)00118-2

Identifiers

DOI

1 reference

29 July 2017

1 reference